Medication info

Innozen 5% Sodium Potassium Glucose Injection 3

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Glucose Monohydrate›50g / 1000mLPotassium Chloride›1.5g / 1000mLSodium Chloride›2g / 1000mL
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
A colorless and transparent injectable solution filled in a plastic container made of high-density polyethylene, which is packaged externally in a translucent manner.
Packaging
500 milliliters
Approval status
Active

MFDS item code 199101329 · Notified 2001.03.24 · Insurance code 640001320

Summary

Main use
Correction of fluid and electrolyte deficiencies (e.g., dehydration) and energy deficiency
Who receives it
Adults
Adult administration
The usual adult dose is 500~1,000mL per dose, administered by intravenous drip infusion. The administration rate should be no more than 0.5g of glucose per kg of body weight per hour. The dose and administration rate may be adjusted appropriately according to age, body weight, and symptoms.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Correction of fluid and electrolyte deficiencies (e.g., dehydration) and energy deficiency

  • Dehydration
View approved original text

This medication is used to replenish body fluids and electrolytes in cases of dehydration or before and after surgery. It also helps provide necessary energy. Through this action, it helps maintain the body's balance and supports health recovery.

How it is given

Adult administration

The usual adult dose is 500~1,000mL per dose, administered by intravenous drip infusion. The administration rate should be no more than 0.5g of glucose per kg of body weight per hour. The dose and administration rate may be adjusted appropriately according to age, body weight, and symptoms.

Precautions

This medication is an injectable solution that contains glucose, potassium, and sodium, which can affect blood sugar and electrolyte levels. Since it contains glucose, it may cause a deficiency in vitamin B1 (thiamine), hence special caution is needed for patients receiving glucose infusion. Allergic reactions may occur; if symptoms of allergy appear, administration should be stopped immediately and appropriate treatment sought. As it contains potassium, there is a risk of hyperkalemia, so patients with impaired kidney function or heart disease should be particularly careful, and serum potassium levels should be monitored frequently. Blood sugar may rise rapidly due to glucose infusion, so patients with diabetes or those needing blood sugar control should closely monitor their blood sugar levels. Due to sodium and chloride components, hypernatremia, hyperchloremia, metabolic acidosis, etc., may occur; therefore, patients with related diseases or those at high risk should exercise caution. There is a risk of hyponatremia, especially in children, the elderly, and post-surgical patients, so serum sodium levels should be checked regularly. Fluid overload may occur, so dosage and speed should be adjusted, and patients with heart failure or lung disease should be cautious. In severe malnutrition patients, refeeding syndrome may occur, so nutrition should be supplied slowly with monitoring. Administration should be avoided in certain patient groups including those with hyperkalemia, fluid overload, and hyperglycemia; and should be used cautiously in patients with kidney impairment or heart failure. Blood sugar, electrolyte, and fluid status should be regularly checked, and it is necessary to inform about any medications being taken due to the possibility of drug interactions. Women who are pregnant or breastfeeding, newborns, children, and the elderly require more careful management at the time of administration. In case of overdose, administration should be stopped immediately, and proper emergency treatment, such as controlling serum potassium levels, should be provided. Compliance with urine output and infusion speed is needed during administration, and care should be taken to prevent air embolism at connection points.

Side effects

  • Anaphylaxis
  • rash
  • itching
  • hyperkalemia
  • hyperglycemia
  • hyperosmolar hyperglycemia
  • hyponatremia
  • fluid overload
  • refeeding syndrome
  • hypernatremia
Show 12 more
  • hyperchloremia
  • hyponatremic encephalopathy
  • cardiac arrest
  • infusion site blisters
  • extravasation
  • venous thrombosis
  • phlebitis
  • infusion site pain
  • cerebral edema
  • pulmonary edema
  • peripheral edema
  • water intoxication

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture entry. Additionally, it is best to store it at room temperature, avoiding extreme heat or cold.

Appearance and packaging

Appearance

A colorless and transparent injectable solution filled in a plastic container made of high-density polyethylene, which is packaged externally in a translucent manner.

Package unit

500 milliliters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.